Abstract
BackgroundGiven that memantine is thought to decrease N-methyl-D-aspartic-acid-related (NMDA) glutamatergic hyperactivity and improve locomotion in rats, we sought to assess the drug's impact on axial symptoms in advanced Parkinson's disease...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have